CagriSema vs Tirzepatide: Weight Loss Results in REDEFINE 4 Trial Paramesh Shamanna posted on the topic LinkedIn In the REDEFINE 2 phase 3a trial involving adults with obesity and diabetes, the use of cagrilintidesemaglutide resulted in a significantly lower body weight than placebo at 68 weeks. Full trial results Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity New England Journal of Medicine Does benadryl make you sleepy? Universal Drugstore Retatrutide Legion inc Obesity pharmacotherapy in older adults: a narrative review of evidence International Journal of Obesity